Home
Healios Co.

Healios Co. Market Share Analysis for July 2026

株式会社ヘリオスは人類の可能性を、人類が手にした最高の技術革新であるバイオ革命という科学技術力で爆発的に広げ、日本の誇るiPSC再生医薬品を活用し、世界中で病に苦しむ患者さんに癒しを届けます。

Health > Biotechnology and Pharmaceuticals

Domainhealios.co.jp

Year Founded2011

Employees51 - 200

Annual Revenue< $1M

Healios Co.

Healios Co. (including company regionals)

healios.co.jp

See more website traffic and engagement information

Total visits to Healios Co.'s top domains

Understand Healios Co. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

healios.co.jp22.4K

See more with Sales Intelligence

Avg. visit duration in Healios Co.'s top domains

Analyze Healios Co. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

healios.co.jp00:01:30

See more with Sales Intelligence

Avg. pageviews on Healios Co.'s top domains

See how Healios Co. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

healios.co.jp3.14

See more with Sales Intelligence

Healios Co. top competitors by domain

Top similar sites in July 2026, ranked by their affinity

ipscell.comCompany NameThe NicheEmployees51 - 200HQUnited States, California, Los AngelesAnnual revenue$10M - $15MTotal visits26.6KHealth > Health - Other

Top technologies used by Healios Co.

These are the website technologies, by industry, used by Healios Co. top domains

Payment & Currencies (21)

PayPal

Widget (3)

Twemoji

Advertising (2)

Google Adsense

Conversion & Analytics (2)

Google Analytics

More Technologies

6

See all

News & Signals from Healios Co.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHealios KK will attend event Jefferies Global Healthcare Conference on Jun 4th '26.NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) - HEALIOS K.K. ("Healios") is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the Jefferies Global Healthcare Conference in New York City as follows:

NewsHealios KK partnered with Jefferson on Apr 17th '26.Healios made poster presentations of its research results of joint research with Thomas Jefferson University on the efficacy of eNK cells, which Healios and Akatsuki Therapeutics are jointly researching and developing, in metastatic uveal melanoma at AACR (American Association of Cancer Research) Annual Meeting 2026 in San Diego, California from April 17 to 22, 2026.